Generic placeholder image

Letters in Drug Design & Discovery

Editor-in-Chief

ISSN (Print): 1570-1808
ISSN (Online): 1875-628X

Synthesis and Anticancer Activity of 2-Aryl-6-diethylaminoquinazolinone Derivatives

Author(s): Thanh Nguyen Le, Daulat Bikram Khadka, Giap Huu Tran, Dung Anh Nguyen, Yifeng Jin, Hue Thi My Van, Van Hung Nguyen and Won-Jea Cho

Volume 13 , Issue 7 , 2016

Page: [684 - 690] Pages: 7

DOI: 10.2174/1570180813666160125222936

Price: $65

Abstract

A series of 6-diethylaminoquinazolin-4(3H)-ones with bulky aryl rings at C2 were designed to cover the vacant space of ligand binding pocket of topoisomerase (topo) I-DNA complex. The desired derivatives were synthesized by thermal cyclodehydration/ dehydrogenation reactions of 5-diethylaminoanthranilamide with substituted aromatic aldehydes. The cytotoxicity of these compounds was evaluated against human epidermoid carcinoma (KB), hepatocellular carcinoma (Hep-G2), human lung carcinoma (LU-1) and human breast carcinoma cells (MCF-7). Most of the synthesized compounds exhibited more potent cytotoxicity than the standard anticancer agent, ellipticine. Among the tested compounds, quinazolinone 1l was the most cytotoxic against all cancer cell lines (IC50: 0.02–0.08 µM). Docking study showed that the new 2-aryl-6- diethylaminoquinazolinones possibly inhibit topo I activities to exhibit anticancer properties.

Keywords: 2-Aryl-6-diethylaminoquinazolinone, 3-arylisoquinoline, bioisosteres, anticancer activity, topoisomerase inhibition.

Graphical Abstract

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy